RBC Europe’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $35K | Hold |
1,068
| – | – | ﹤0.01% | 362 |
|
|
2022
Q1 | $77K | Hold |
1,068
| – | – | ﹤0.01% | 312 |
|
|
2021
Q4 | $98K | Buy |
1,068
+433
| +68% | +$39.7K | ﹤0.01% | 285 |
|
|
2021
Q3 | $80.5K | Buy |
635
+67
| +12% | +$8.5K | ﹤0.01% | 459 |
|
|
2021
Q2 | $94.5K | Sell |
568
-110
| -16% | -$18.3K | ﹤0.01% | 444 |
|
|
2021
Q1 | $123K | Sell |
678
-619
| -48% | -$113K | 0.01% | 368 |
|
|
2020
Q4 | $259K | Buy |
1,297
+507
| +64% | +$101K | 0.01% | 246 |
|
|
2020
Q3 | $173K | Sell |
790
-60
| -7% | -$13.2K | 0.01% | 270 |
|
|
2020
Q2 | $162K | Sell |
850
-575
| -40% | -$110K | 0.01% | 271 |
|
|
2020
Q1 | $221K | Buy |
1,425
+60
| +4% | +$9.3K | 0.02% | 199 |
|
|
2019
Q4 | $114K | Hold |
1,365
| – | – | 0.01% | 320 |
|
|
2019
Q3 | $92.4K | Sell |
1,365
-125
| -8% | -$8.47K | 0.01% | 347 |
|
|
2019
Q2 | $99K | Hold |
1,490
| – | – | 0.01% | 340 |
|
|
2019
Q1 | $82.8K | Buy |
1,490
+312
| +26% | +$17.3K | 0.01% | 363 |
|
|
2018
Q4 | $58.4K | Buy |
1,178
+258
| +28% | +$12.8K | 0.01% | 406 |
|
|
2018
Q3 | $79.4K | Sell |
920
-203
| -18% | -$17.5K | 0.01% | 390 |
|
|
2018
Q2 | $65.2K | Buy |
1,123
+304
| +37% | +$17.6K | 0.01% | 421 |
|
|
2018
Q1 | $33K | Buy |
819
+278
| +51% | +$11.2K | ﹤0.01% | 561 |
|
|
2017
Q4 | $18.9K | Buy |
541
+399
| +281% | +$13.9K | ﹤0.01% | 690 |
|
|
2017
Q3 | $4.71K | Buy |
+142
| New | +$4.71K | ﹤0.01% | 959 |
|